Beijing Sunho Pharmaceutical Co., Ltd.

Founded in 2000, we are an innovative pharmaceutical company specializing in advanced drug delivery systems. Our three core technologies - controlled-release formulations, orally disintegrating tablets, and complex injectables - enable us to provide end-to-end CDMO services from preclinical development to commercial manufacturing. With EMA certification (2022) and successful US FDA inspection (2023), we are committed to becoming a globally leading CMC & CMO service provider with globally compliant quality systems.